Faculty Appointments
Patient Care Settings
Cancer, Radiation Oncology
Biography
It is a privilege to care for our patients. I am committed to providing personalized radiation treatment of the highest quality, as well as compassionate care. My areas of expertise include prostate and head and neck cancers.
Conditions I Treat:
- Prostate cancer
- Head and neck cancers
- Breast cancer
- Other cancers
Credentials
Education
1993
PHD | Case Western Reserve University School of Medicine
2001
MD | Yale University
Post-doctoral Training & Residency
07/01/2002 - 06/30/2006
Residency in Radiation Oncology at University of Rochester Medical Center
06/01/2001 - 06/01/2002
Internship in Internal Medicine at Rochester General Hospital
06/01/1993 - 12/31/1994
Fellowship at Case Western Reserve University Endodontics Residency
VIEW ALL expand_more
Awards
2023
Exceptional Women In Medicine 2023
Sponsor: Becker's Hospital Review
2018
Civic Service Award, Us TOO Rochester
Sponsor: Us TOO Rochester
2017
AAMC Mid-Career Woman Faculty Leadership Development Seminar 12/2017
Sponsor: AAMC
2017
Health Care Achievement Awards--Health Care Innovation
Sponsor: Rochester Business Journal
Location: Rochester, NY
2016
Educator of the Year
Sponsor: Association of Residents in Radiation Oncology
2013
Patient- and Family- Centered ICARE High Performance Award
2012 - 2017
Civic Service Award, Us TOO Rochester
Sponsor: Us TOO Rochester
2012
Educator of the Year
Sponsor: Association of Residents in Radiation Oncology
2012
Patient- and Family-Centered ICARE High Performance Award
Sponsor: University of Rochester Medical Center
2005
Upstate New York Society of Therapeutic Radiology and Oncology Fall Meeting Resident Presenter Award
Location: Syracuse, NY
2005
ASTRO Translational Research in Radiation Oncology Symposium Travel Grant Award
2001
Janet M.Glasgow Memorial Achievement Citations
Sponsor: Yale University School of Medicine
Location: New Haven, Connecticut
2000
Clyde Swift Award for Outstanding Medical Student
Sponsor: Yale University School of Medicine
Location: New Haven, Connecticut
VIEW ALL expand_more
Clinical Trials
A Phase II Double-Blinded, Placebo-Controlled Trial of PROstate OligoMETastatic RadiotHErapy With or Without ANdrogen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG Promethean)
Lead Researcher: Hong Zhang
This phase II trial tests whether relugolix and radiation therapy works to shrink tumors in patients with prostate cancer that has spread in a limited way to 1 to 5 other parts of the body (oligometastatic). Testosterone can cause the growth of prostate cancer cells. Relugolix lowers the amount of testosterone made by the body. This may help stop the growth of tumor cells that need testosterone to grow. Giving relugolix with radiation therapy may help lower the chance of prostate cancer growing or spreading.
View Study Details
Randomized Phase III Trial Incorporating Abiraterone Acetate With Prednisone and Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy,Randomized Phase III Trial Incorporating Abiraterone Acetate With Prednisone and Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy
Lead Researcher: Hong Zhang
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
View Study Details
Publications
Journal Articles
7/6/2023
Jagsi R, Barlow WE, Woodward WA, Connolly E, Mahtani R, Shumway D, Speers C, Stecklein SR, Zeidan Y, Zhang H, Sharma P, Pusztai L, Hortobagyi GN, Kalinsky K. "Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial." JAMA oncology.. 2023 Jul 6; Epub 2023 Jul 06.
2023
Hardy SJ, Bandyopadhyay S, Yang H, Williams A, Gudina A, Cummings MA, Zhang H, Singh DP, Chen Y, Mohile NA, Janelsins MC, Milano MT. "Stroke death in patients receiving radiation for head and neck cancer in the modern era." Frontiers in oncology.. 2023 13:1111764. Epub 2023 Jun 15.
2022
Kerns SL; Amidon Morlang A; Lee SM; Peterson DR; Marples B; Zhang H; Bylund K; Rosenzweig D; Hall W; De Ruyck K; Rosenstein BS; Stock RG; Gómez-Caamaño A; Vega A; Sosa-Fajardo P; Taboada-Valladares B; Aguado-Barrera ME; Parker C; Veldeman L; Fonteyne V; Bultijnck R; Talbot CJ; Symonds RP; Johnson K; Rattay T; Webb A; Lambrecht M; de Ruysscher D; Vanneste B; Choudhury A; Elliott RM; Sperk E; Herskind C; Veldwijk MR; Rancati T; Avuzzi B; Valdagni R; Azria D; Farcy Jacquet MP; Chang-Claude J; et al. "Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer". Radiother Oncol. 2022; 168: 75-82.
Books & Chapters
2009
Chapter Title: Breast Cancer
Book Title: Principles and Practice of Radiation Therapy
Author List: Uschold G; Zhang H
Edited By: Washington CM; Leaver D
Published By: Mosby Elsevier 2009
VIEW ALL PUBLICATIONS
Videos
play_circle_filled
Radiation Oncology at Highland Hospital
Reviews
At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information.